A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisM. Gironi, Gianvito Martino, ME Rodegher et al.|Multiple Sclerosis Journal|2008Cited by 96
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy studySebastiano Bucello, Luca Prosperini, Pietro Annovazzi et al.|Journal of Neurology|2021Cited by 22
Striatal hand in Parkinson’s disease: the re-evaluation of an old clinical signFrancesca Spagnolo, Maria Antonietta Volonté, Mario Fichera et al.|Journal of Neurology|2013Cited by 16
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders RegisterPaola Mosconi, Marinella Clerico, Tommaso Guerra et al.|Neurological Sciences|2023Cited by 9
Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders registerRoberto Bergamaschi, Maura Danni, Ettore Beghi et al.|Neurological Sciences|2022Cited by 4